Approaches to improve the efficiency of molecular optimizations have received great attention and numerous efficiency metrics have been introduced to assist in this effort. Optimization of properties is equally important to optimization of potency and therefore these metrics contain potency versus property calculations. Widespread use of a metric does not guarantee its accuracy and a further understanding of which, if any, metric increases the probability of success was sought. An analysis of LE, LELP and LipE based on theoretical and experimental data was performed demonstrating that LipE most strongly correlates with compound quality as defined by enthalpy-driven binding. The basis for the prioritization of LipE over other metrics in enth...
In drug discovery, active compounds identified by screening or other approaches usually bind to thei...
a<p>encapsulation efficiency 1 (EE1%) was calculated as the percentage of the amount of ASOs in lipo...
Ligand efficiency is a widely used design parameter in drug discovery. It is calculated by scaling a...
Over the past 15 years there have been extensive efforts to understand and reduce the high attrition...
Lipophilic efficiency indices such as LLE and LELP were suggested to support balanced optimization o...
A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med....
The judicious application of ligand or binding efficiency metrics, which quantify the molecular prop...
A key part of drug design and development is the optimization of molecular interactions between an e...
A drug molecule should bind to its target with high affinity and selectivity. Since the binding affi...
The use of composite metrics that normalise biological potency values in relation to markers of phys...
<p>Ligand efficiency (LE), Lipophilic Efficiency (LipE) and Fit Quality (FQ) values of C1-C10 hits.<...
The practices and tactics employed in successful optimizations are examined, judged from the traject...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
IMPORTANCE OF THE FIELD: The role of lipophilicity in determining the overall quality of candidate d...
The use of ligand binding thermodynamics has been proposed as a potential success factor to accelera...
In drug discovery, active compounds identified by screening or other approaches usually bind to thei...
a<p>encapsulation efficiency 1 (EE1%) was calculated as the percentage of the amount of ASOs in lipo...
Ligand efficiency is a widely used design parameter in drug discovery. It is calculated by scaling a...
Over the past 15 years there have been extensive efforts to understand and reduce the high attrition...
Lipophilic efficiency indices such as LLE and LELP were suggested to support balanced optimization o...
A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med....
The judicious application of ligand or binding efficiency metrics, which quantify the molecular prop...
A key part of drug design and development is the optimization of molecular interactions between an e...
A drug molecule should bind to its target with high affinity and selectivity. Since the binding affi...
The use of composite metrics that normalise biological potency values in relation to markers of phys...
<p>Ligand efficiency (LE), Lipophilic Efficiency (LipE) and Fit Quality (FQ) values of C1-C10 hits.<...
The practices and tactics employed in successful optimizations are examined, judged from the traject...
Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literatu...
IMPORTANCE OF THE FIELD: The role of lipophilicity in determining the overall quality of candidate d...
The use of ligand binding thermodynamics has been proposed as a potential success factor to accelera...
In drug discovery, active compounds identified by screening or other approaches usually bind to thei...
a<p>encapsulation efficiency 1 (EE1%) was calculated as the percentage of the amount of ASOs in lipo...
Ligand efficiency is a widely used design parameter in drug discovery. It is calculated by scaling a...